Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples